Nakano et al., in their experimental study in mice with ischemic stroke, have shown that the therapeutic window of recombinant ADAMTS13 administration is higher compared to tissue-type plasminogen t-PA thrombolysis [36]. This evidence concerns the gene PLAT and ischemic stroke.